CURY3 shares closed October at their lowest level of the year, but the third quarter of 2026 painted a different picture than the stock price suggested: a record net income of R$ 369.6 million, coming in 19% above analyst expectations, and positive cash flow for the 30th consecutive quarter. The real challenge lies in contract cancellations, which doubled quarter-over-quarter as a direct result of tighter credit approval standards at Caixa Econômica Federal for buyers under the Minha Casa Minha Vida affordable housing program.
What Happened with CURY3?
On November 10, Cury Construtora released its Q3 2026 earnings, posting a net income of R$ 369.6 million—a 30.5% increase compared to Q3 2025 and 19% above the median analyst estimate compiled by LSEG (R$ 311 million). Net revenue reached R$ 1.837 billion, also beating consensus, with a gross margin of 39.5%. The company described the quarter as marking "new records for net revenue and net income."
For the first nine months of 2026, revenue totaled R$ 5.141 billion, up 29.2%, while core net income crossed the R$ 1 billion mark, reaching R$ 1.032 billion—31.6% higher than the same period in 2025. This is the first time the company has surpassed this threshold over a nine-month period.
Underpinning Cury's investment thesis is its consistent cash generation—R$ 253.6 million for the quarter, up 8.8% from Q3 2025 and marking the 30th consecutive quarter of positive operating cash flow. Return on equity (ROE) reached 73.2%, up 2.6 percentage points from Q3 2025, while unit production reached 6,304 units during the period—an all-time company record and 28.4% higher than the same quarter last year.
Quarterly record; 29.7% growth over Q3 2025.
30th consecutive positive quarter; +8.8% over Q3 2025.
Return on equity; +2.6 percentage points vs. Q3 2025.
The landbank (available land inventory for future launches) reached R$ 26.1 billion in potential sales value (VGV), an 11.8% increase over Q3 2025. For a company that launches R$ 2.1 billion per quarter, this represents more than three years of future project launches, providing strong visibility into future revenue. The operational preview released in October had already signaled this pipeline, and the financial results confirmed that sales volume converted into cash at the same pace.
Why Cancellations Doubled and What It Means for Investors
The primary point of concern for the quarter is the surge in contract cancellations. Cancellations totaled R$ 358.2 million in Q3 2026: 59.3% higher than in Q3 2025 and more than double the figure recorded in the second quarter of 2026. The proportion of cancellations relative to gross sales jumped from 7.7% in Q2 2026 to 15% this quarter, compared to 11% a year earlier.
Management's explanation is straightforward: starting in June, Caixa Econômica Federal tightened credit approval criteria, particularly for buyers with informal income—the majority demographic in the Minha Casa Minha Vida program. Buyers secure units based on financing simulations, but when applying for the actual mortgage, the state-run bank approves a lower amount than projected or denies the loan entirely. A strike by Caixa employees in September added further processing delays. As a result, Cury repossessed units that failed to secure mortgage funding and put them back on the market.
This spike is not unique to Cury. According to data compiled by Portas, Cury, MRV, Plano&Plano, and Tenda combined recorded R$ 1.1 billion in cancellations during the third quarter, a 65.5% increase across the sector. MRV, which operates in the same affordable housing segment, registered a similar jump in this metric. This pattern confirms that the pressure stems from credit conditions rather than specific issues with product quality or location.
Net sales figures remained positive: with gross sales growing 16.7% over Q3 2025, net sales—after accounting for cancellations—stood at R$ 2.035 billion, still 11.4% higher than in Q3 2025. The sales velocity (net VSO) was 39.7%, virtually unchanged from the second quarter (40.5%) and just 0.9 percentage points below Q3 2025. While the business model absorbed the shock, the pace of cancellations in Q4 2026 remains the most heavily weighted variable for the investment thesis moving forward.
Banco Safra characterized the results as "solid and slightly above estimates," noting that Cury exceeded the bank's sales projection by 6% and its cash generation estimate by 13%. XP, which added Cury to its model portfolio in September citing disciplined cash returns, published a note titled "resilient operational performance and robust cash generation." Both institutions maintained favorable stances on the stock following the earnings release.
Dividend of R$ 0.65: Record Date Set for November 13
On November 9, the Board of Directors approved the distribution of R$ 200 million in interim dividends—equivalent to R$ 0.64925 per share. The record date is November 13, 2026: shareholders holding the stock on that Friday are entitled to the payout. Starting November 16, the shares will trade ex-dividend, and payment will be distributed on November 30.
Calculated against the previous day's closing price of R$ 27.64 prior to the announcement, the dividend represents a yield of 2.35%—roughly equivalent to two months of the gross CDI rate (with the CDI rate at 13.65% per year, it yields about 2.16% over two months before income taxes). For income-focused investors, the estimated trailing twelve-month yield, based on the closing price of R$ 26.87 on November 10, sits near 16%—calculated using the R$ 4.30 per share distributed over the past twelve months, excluding this new R$ 0.65 payout.
This payment will be imputed toward the mandatory minimum dividends for the 2026 fiscal year. It is not an "extraordinary dividend" stacked on top of the mandatory minimum, but rather a portion of it paid in advance. In the twelve months ending in the third quarter, Cury distributed R$ 1.513 billion in shareholder distributions—more than double the equivalent window from the previous year—reinforcing that this accelerated payout policy is an ongoing practice rather than a one-off event.
The Q3 2026 results confirm the operational thesis—earnings beating expectations, cash flow remaining positive, and steady dividends—while acknowledging short-term risks. If Caixa's credit constraints persist into Q4 2026, net sales velocity will put pressure on revenue recognized in subsequent quarters. The site's target price (R$ 29.75) stands above the current market quote of R$ 26.87, with a "hold" recommendation. For investors currently holding the stock who are weighing their options, exit criteria should be based on operational metrics—such as a continuous deterioration in VSO or cancellations exceeding 15% for more than two quarters—rather than short-term price movements.
Key Metrics to Watch in Q4 2026
Pace of Cancellations — if cancellations remain above 12% of gross sales in Q4 2026, pressure on net sales will persist. In Q3 2026, they stood at 15%. Cury indicated it proactively cancelled contracts for clients lacking credit approval in July; if Caixa eases its criteria, part of this volume could be recovered.
Caixa's Credit for Informal Income — any shift in Caixa Econômica Federal's stance on Minha Casa Minha Vida approval criteria serves as the most direct catalyst for the investment thesis. Statements from the bank or Cury during the Q4 2026 earnings conference call (scheduled for February 2027) will be the next key checkpoint.
Net Sales Velocity (VSO) — stood at 39.7% in Q3 2026 and 40.6% in Q3 2025. Any further decline below 37% would signal that cancellations are hindering the company's ability to convert launches into cash within the quarter.
